Zijlker et al. 2024 “The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.” Ann Surg Oncol 31: 5324-5330 PMID:38762644 Surgical Staff: Andrew Spillane
2023
Dayaratna et al. 2023 “Trends and variations in post-mastectomy breast reconstruction rates in Australia over 10 years.” ANZ J Surg 93: 242-250 PMID:36651629 Surgical Staff: Andrew Spillane Dempsey et al. 2023 “Patient-reported health-related quality of life outcomes following mastectomy for breast cancer, with immediate, delayed or no breast reconstruction: Four-year follow-up from a prospective cohort study.” Breast 71: 122-131 PMID:37573653 Surgical Staff: Andrew Spillane Dempsey et al. 2023 “Benefits and harms of breast cancer screening revisited: a large, retrospective cross-sectional study quantifying treatment intensity in women with screen-detected versus non-screen-detected cancer in Australia and New Zealand.” BMJ Oncol 2: e000100 PMID:39886492 Surgical Staff: Andrew Spillane Holtkamp et al. 2023 “Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection.” J Surg Oncol 128: 97-104 PMID:36971691 Surgical Staff: Andrew Spillane Mao et al. 2023 “Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approach.” J Transl Med 21: 257 PMID:37055772 Surgical Staff: Andrew Spillane Miller et al. 2023 “Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma.” JAMA Netw Open 6: e236356 PMID:37074717 Surgical Staff: Andrew Spillane Nickel et al. 2023 “Women's views about current and future management of Ductal Carcinoma in Situ (DCIS): A mixed- methods study.” PLoS One 18: e0288972 PMID:37478123 Surgical Staff: Andrew Spillane Paver et al. 2023 “Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma.” Pathology 55: 555-560 PMID:36400594 Surgical Staff: Andrew Spillane Paver et al. 2023 “Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.” JAMA Dermatol 159: 1359-1367 PMID:37910123 Surgical Staff: Andrew Spillane Reijers et al. 2023 “IFN- γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.” J Exp Med 220: e20221952 PMID:36920329 Surgical Staff: Andrew Spillane Schoenfeldt et al. 2023 “Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma.” Ann Surg Oncol 30: 2354-2361 PMID:36463358 Surgical Staff: Andrew Spillane Wilding et al. 2023 “Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1.” Fam Cancer 22: 499-511 PMID:37335380 Surgical Staff: Katrina Moore
8
Made with FlippingBook - professional solution for displaying marketing and sales documents online